174 related articles for article (PubMed ID: 37417362)
1. Overexpression of SERPINA3 suppresses tumor progression by modulating SPOP/NF‑κB in lung cancer.
Jin Y; Zhang Y; Huang A; Chen Y; Wang J; Liu N; Wang X; Gong Y; Wang W; Pan J
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37417362
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
[TBL] [Abstract][Full Text] [Related]
3. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
4. SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
Cao LL; Pei XF; Qiao X; Yu J; Ye H; Xi CL; Wang PY; Gong ZL
Dig Dis Sci; 2018 Sep; 63(9):2309-2319. PubMed ID: 29855767
[TBL] [Abstract][Full Text] [Related]
5. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
6. SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC.
Ko E; Kim JS; Bae JW; Kim J; Park SG; Jung G
Redox Biol; 2019 Jun; 24():101217. PubMed ID: 31121493
[TBL] [Abstract][Full Text] [Related]
7. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
9. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.
Fu L; Shi K; Wang J; Chen W; Shi D; Tian Y; Guo W; Yu W; Xiao X; Kang T; Wang S; Huang W; Deng W
Mol Cancer; 2014 Apr; 13():89. PubMed ID: 24766673
[TBL] [Abstract][Full Text] [Related]
10. KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma.
Wang B; Jing T; Jin W; Chen J; Wu C; Wang M; Liu Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):170. PubMed ID: 32854746
[TBL] [Abstract][Full Text] [Related]
11. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Kim MK; Jeon YK; Woo JK; Choi Y; Choi DH; Kim YH; Kim CW
Mol Cancer; 2011 Aug; 10():98. PubMed ID: 21843371
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
13. Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G
Xue T; Chen Y; Xu J; Du W; Kong P; Zhang X
Int J Oncol; 2023 May; 62(5):. PubMed ID: 36929198
[TBL] [Abstract][Full Text] [Related]
14. HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3.
Sun J; Wang L
BMC Cancer; 2022 Apr; 22(1):366. PubMed ID: 35387643
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-antichymotrypsin contributes to stem cell characteristics and enhances tumorigenicity of glioblastoma.
Lara-Velazquez M; Zarco N; Carrano A; Phillipps J; Norton ES; Schiapparelli P; Al-Kharboosh R; Rincon-Torroella J; Jeanneret S; Corona T; Segovia J; Jentoft ME; Chaichana KL; Asmann YW; Quiñones-Hinojosa A; Guerrero-Cazares H
Neuro Oncol; 2021 Apr; 23(4):599-610. PubMed ID: 33249487
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells.
Zhou J; Cheng Y; Tang L; Martinka M; Kalia S
Oncotarget; 2017 Mar; 8(12):18712-18725. PubMed ID: 27213583
[TBL] [Abstract][Full Text] [Related]
19. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.
Chen C; Liu Y; Chen Y; Xu J
Cancer Biol Ther; 2011 Nov; 12(9):797-807. PubMed ID: 21900746
[TBL] [Abstract][Full Text] [Related]
20. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
[Next] [New Search]